(Date:11/24/2009)...EN,Italy,November24/PRNewswire/--HealthRoboticstod...ewithagroupofselected,investors.Thisrecentlyformed...RoboticsCanada,Inc.andwillmarket,install,andsuppor...ncludesthe,revolutionaryproductofferingsi.v.STATIO...aInc.willalsoprovideassistanceonan"asneeded,basis"...
(Date:11/24/2009)...TTLE,Nov.24/PRNewswire-FirstCall/--CellTherapeutic...tatthe21stAnnualPiperJaffrayHealthCareConference.T...kPalaceHotel. ,, CTIwillpresentonTuesday,Decemb...audiowebcastofCTI,spresentationwillbeavailableat w...orreplayafterwards. , ,PiperJaffrayHealthCareConf...
(Date:11/23/2009)...omputing promises ultra-fast communication, comput...information. But trying to use quantum states as c...siness. Now two physicists have shown, mathematica...ntum communication, while keeping the information ...e of Physical Review Letters and highlighted wit...
(Date:11/23/2009)...SISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioScie...ctdevelopmentcompanythatidentifiesandadvancesadive...iousstagesofdevelopment,todayreportedthatCytopia(A...uatingCYT387,apotent,orally-administeredJAK1/JAK2i...hester,Minnesota.AproposaltomergeCytopiaintoYMhasb...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4...t. 14 Dr. Eliane Gluckman, recognized,as a pionee...transplantation, has joined the team at CORD:USE C...complished physician as Dr. Gluckman join our,team...ORD:USE," says Edward,Guindi M.D., President and C...recognized as the pioneering physician,who perform...
...t. 14 LI-COR Biosciences introduces a,new, novel ...he Odyssey(R),Infrared Imaging system. The Odyssey...stained and fluoresces in the 700 and 800 nm chann... for use with polyacrylamide gels,and can be used ...ring,electrophoresis, to monitor transfer efficien...
...f the Office of National Drug Control Policy to Mo...icines Become Bad Drugs, FRAZER, Pa., Oct. 14 Ce...t is embarking on a national educational,program d...s, caregivers,and the public about the importance ... opioid medications. The initiative, When Good Med...
Other Biology Technology:CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team 2CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team 3LI-COR Introduces the Odyssey(R) Two-Color NIR Fluorescent Protein Molecular Weight Marker 2Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications 2Rabbit IgG ELISA Development Kit, SensiFlex with Fluorocillin Green 495/525 from Molecular Probes (Invitrogen)
Human TNF-alpha from BioVision
Mouse Anti-Bovine WC1 Monoclonal Antibody, FITC Conjugated from AbD Serotec
...ns the basic components required for the developme...binant Feline IL-10 in cell culture supernates and...run ELISAs on approximately fifteen 96-well plates... The assay is run as summarized in the General ELI...
Biology Products: